vs 7,393 other HR bills in the 115th — cohort avg 50d
Summary
Humane Cosmetics Act This bill prohibits testing cosmetics on animals, effective on the date that is one year after enactment of this bill. No cosmetic may be sold or transported if the final product or any component was developed or manufactured using animal testing after that date, effective three years after enactment of this bill.
Lobbying filings that explicitly cite this bill (26)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Cited source text, amounts, lobbyists, and targets
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions.
- S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions.
- H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions.
- H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions.
- S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions.
- Issues regarding drug pricing.
- Issues related to diagnostic reform.
- S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions
- S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions
- S 204/HR 878, Right to Try Act of 2017, regarding all provisions
- HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions
- HR 1703, Medical Product Communications Act of 2017, regarding all provisions
- Issues related to VA procurement of medical devices
- HR 2474, Medical Product Review Harmonization Act, regarding all provisions
- HR 2144, Risk Based Classification of Accessories Act
- Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects
- S.1113, "Personal Care Products Safety Act", regarding all provisions
- HR 2790, "Humane Cosmetics Act", regarding all provisions
- HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions
- Issues regarding medical device repeal
- Issues regarding NIH Funding
- HR 2164, "Medical Device Safety Act", regarding all provisions
- Issues related to 340B
- Issues related to HIV vaccines
- S. 2852, "Pandemic & All Hazards Preparedness and Advancing Innovations Act of 2018", regarding all provisions.
- Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. (House version)
- HR 5492, "MOTHER Act of 2018", regarding all provisions.
- Issues related to access to essential surgery
- Issues related to contact lens safety
- HR 6, "SUPPORT for Patients and Communities Act", regarding all provisions.
- S. 2315, "Over-the-Counter Drug Safety, Innovation, and Reform Act", regarding all provisions.
- HR 5333 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018", regarding all provisions.
- Issues related to antimicrobial resistance
- Issues related to regulations on medication product packaging
- H.R. 6294, " Re-Valuing Anti-Microbial Products Act of 2018", regarding all provisions
- H.R. 1318, "Preventing Maternal Deaths Act of 2018", regarding all provisions
Client expense: $2,340,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions.
- S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions.
- H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions.
- H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions.
- S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions.
- Issues regarding drug pricing.
- Issues related to diagnostic reform.
- S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions
- S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions
- S 204/HR 878, Right to Try Act of 2017, regarding all provisions
- HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions
- HR 1703, Medical Product Communications Act of 2017, regarding all provisions
- Issues related to VA procurement of medical devices
- HR 2474, Medical Product Review Harmonization Act, regarding all provisions
- HR 2144, Risk Based Classification of Accessories Act
- Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects
- S.1113, "Personal Care Products Safety Act", regarding all provisions
- HR 2790, "Humane Cosmetics Act", regarding all provisions
- HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions
- Issues regarding medical device repeal
- Issues regarding NIH Funding
- HR 2164, "Medical Device Safety Act", regarding all provisions
- Issues related to 340B
- Issues related to HIV vaccines
- S. 2852, "Pandemic & All Hazards Preparedness and Advancing Innovations Act of 2018", regarding all provisions.
- Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. (House version)
- HR 5492, "MOTHER Act of 2018", regarding all provisions.
- Issues related to access to essential surgery
- Issues related to contact lens safety
- HR 6, "SUPPORT for Patients and Communities Act", regarding all provisions.
- S. 2315, "Over-the-Counter Drug Safety, Innovation, and Reform Act", regarding all provisions.
- HR 5333 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018", regarding all provisions.
- Issues related to antimicrobial resistance
- Issues related to regulations on medication product packaging
- H.R. 6294, " Re-Valuing Anti-Microbial Products Act of 2018", regarding all provisions
Client expense: $1,980,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions.
- S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions.
- H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions.
- H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions.
- S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions.
- Issues regarding drug pricing.
- Issues related to diagnostic reform.
- S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions
- S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions
- S 204/HR 878, Right to Try Act of 2017, regarding all provisions
- HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions
- HR 1703, Medical Product Communications Act of 2017, regarding all provisions
- Issues related to VA procurement of medical devices
- HR 2474, Medical Product Review Harmonization Act, regarding all provisions
- HR 2144, Risk Based Classification of Accessories Act
- Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects
- S.1113, "Personal Care Products Safety Act", regarding all provisions
- HR 2790, "Humane Cosmetics Act", regarding all provisions
- Issues related to over the counter medicine regulatory reform
- HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions
- Issues regarding medical device repeal
- Issues regarding NIH Funding
- HR 2164, "Medical Device Safety Act", regarding all provisions
- Issues related to 340B
- Issues related to HIV vaccines
- S. 2852, "Pandemic & All Hazards Preparedness and Advancing Innovations Act of 2018", regarding all provisions.
- Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. (House version)
- HR 5492, "MOTHER Act of 2018", regarding all provisions.
- Issues related to access to essential surgery
- Issues related to contact lens safety
Cited source text, amounts, lobbyists, and targets
H.R.142, Dangerous Products Warning Act
H.R.575, Cosmetic Modernization Amendments of 2017
H.R.2728, Cleaning Product Labeling Act of 2017
H.R.2790, Humane Cosmetics Act
H.R.3409, Anti-Pyramid Promotional Scheme Act of 2017
H.R.4544, Consumer Data Protection Act
H.R.5165, Ending Forced Arbitration for Victims of Data Breaches Act of 2018
H.R.5166, Protecting Consumer Information Act of 2018
H.R.5548, To require a study on the presence of personal care products in drinking water
S.2003, FDA Cosmetic Safety and Modernization Act
S.2124, Consumer Privacy Protection Act of 2017
S.2179, Data Security and Breach Notification Act
Client expense: $150,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R.142, Dangerous Products Warning Act
H.R.575, Cosmetic Modernization Amendments of 2017
H.R.2728, Cleaning Product Labeling Act of 2017
H.R.2790, Humane Cosmetics Act
H.R.3409, Anti-Pyramid Promotional Scheme Act of 2017
H.R.4544, Consumer Data Protection Act
H.R.5165, Ending Forced Arbitration for Victims of Data Breaches Act of 2018
H.R.5166, Protecting Consumer Information Act of 2018
H.R.5548, To require a study on the presence of personal care products in drinking water
S.2003, FDA Cosmetic Safety and Modernization Act
S.2124, Consumer Privacy Protection Act of 2017
S.2179, Data Security and Breach Notification Act
Client expense: $150,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions.
- S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions.
- H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions.
- H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions.
- S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions.
- Issues regarding drug pricing.
- Issues related to diagnostic reform.
- Issues related to blood glucose meters.
- S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions
- S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions
- S 204/HR 878, Right to Try Act of 2017, regarding all provisions
- HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions
- HR 1703, Medical Product Communications Act of 2017, regarding all provisions
- Issues related to VA procurement of medical devices
- HR 2474, Medical Product Review Harmonization Act, regarding all provisions
- HR 2144, Risk Based Classification of Accessories Act
- Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects
- S.1113, "Personal Care Products Safety Act", regarding all provisions
- HR 2790, "Humane Cosmetics Act", regarding all provisions
- Issues related to over the counter medicine regulatory reform
- HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions
- Issues regarding medical device repeal
- Issues regarding NIH Funding
- HR 2164, "Medical Device Safety Act", regarding all provisions
- Issues related to 340B
- Issues related to HIV vaccines
- Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs.
- HR 5492, "MOTHER Act of 2018", regarding all provisions.
Cited source text, amounts, lobbyists, and targets
Legislation: H.R. 1818 Big Cat Public Safety Act H.R. 2790 Humane Cosmetics Act H.R. 1753/S. 741 Opportunities for Fairness in Farming Act H.R. 1752/S. 740 Voluntary Checkoff Program Participation Act H.R. 2651 Thoroughbred Horseracing Integrity Act H.R. 1494/S. 654 Preventing Animal Cruelty and Torture Act H.R. 1847 Prevent All Soring Tactics Act H.R. 1338 Horse Protection Amendments Act H.R. 909/S. 322 Pet and Women Safety Act H.R. 113 Safeguarding American Food Exports Act H.R. 1456/S. 793 Shark Fin Trade Elimination Act H.R. 1406 Dog and Cat Meat Trade Prohibition Act of 2017 H.R. 1368/S. 503 Animal Welfare Accountability and Transparency Act Farm Bill (not yet introduced) Puppy Mill Bills (not yet introduced) H.R. 2887 No Regulation without Representation Act of 2017 Animal Welfare in Agricultural Research Endeavors Act (not yet introduced) H.R. 424/S. 164 Gray Wolf State Management Act S. 733 Sportsmens Act S. 1514 Hunting Heritage and Environmental Legacy Preservation (HELP) for Wildlife Act H.R. 226 African Elephant Conservation and Legal Ivory Possession Act H.R. 1243 Battlefield Excellence through Superior Training Practices Act H.R. 2810 and S. 1519 National Defense Authorization Act for Fiscal Year 2018 H.R. 1438 Refuge from Cruel Trapping Act H.R. 1584 Orca Responsibility and Care Advancement Act H. Res. 244 Expressing support for Japan to end its whaling in all forms and to strengthen measures to conserve whale populations H.R. 1817 Chemical Poisons Reduction Act H.R. 2542 Federal Bird-Safe Buildings Act of 2017 H.R. 2083 Endangered Salmon and Fisheries Predation Prevention Act H.R. 1759 Traveling Exotic Animal and Public Safety Protection Act S. 951 Regulatory Accountability Act H.R. 816 FACT Act H.R. 3197 Preventing Unkind and Painful Procedures and Experiments on Respected Species (PUPPERS) Act Rulemaking and Federal Government Decisions and Policies: Potential revisions to the Endangered Species Act Upgrading dog dealer standards Organic Livestock and Poultry Protection Rule Horse Protection Act Rule Animal Welfare Act and Horse Protection Act online records Nominations Sonny Perdue, Department of Agriculture
Cited source text, amounts, lobbyists, and targets
H.R.142, Dangerous Products Warning Act
H.R.575, Cosmetic Modernization Amendments of 2017
H.R.2728, Cleaning Product Labeling Act of 2017
H.R.2790, Humane Cosmetics Act
H.R.3409, Anti-Pyramid Promotional Scheme Act of 2017
H.R.4544, Consumer Data Protection Act
H.R.5165, Ending Forced Arbitration for Victims of Data Breaches Act of 2018
H.R.5166, Protecting Consumer Information Act of 2018
S.2003, FDA Cosmetic Safety and Modernization Act
S.2124, Consumer Privacy Protection Act of 2017
S.2179, Data Security and Breach Notification Act
Client expense: $150,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions.
- S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions.
- H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions.
- H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions.
- S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions.
- Issues regarding drug pricing.
- Issues related to diagnostic reform.
- Issues related to blood glucose meters.
- S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions
- S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions
- S 204/HR 878, Right to Try Act of 2017, regarding all provisions
- HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions
- HR 1703, Medical Product Communications Act of 2017, regarding all provisions
- Issues related to VA procurement of medical devices
- HR 2474, Medical Product Review Harmonization Act, regarding all provisions
- HR 2144, Risk Based Classification of Accessories Act
- Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects
- S.1113, "Personal Care Products Safety Act", regarding all provisions
- HR 2790, "Humane Cosmetics Act", regarding all provisions
- Issues related to over the counter medicine regulatory reform
- HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions
- Issues regarding medical device repeal
- Issues regarding NIH Funding
- HR 2164, "Medical Device Safety Act", regarding all provisions
- Issues related to 340B
- Issues related to HIV vaccines
Cited source text, amounts, lobbyists, and targets
Lobbied in support of the following full bills: H.R. 909, the Pet and Women Safety Act; H.R. 1456, the Shark Fin Sales Elimination Act; H.R. 1494, the Preventing Cruelty and Torture Act; H.R. 1847, the Prevent All Soring Tactics Act; H.R. 2790, the Humane Cosmetics Act; H.R. 2651, the Horseracing Integrity Act; H.R.1406, the Dog and Cat Meat Trade Prohibition Act; and H.R.4202, Parity in Animal Cruelty Enforcement Act.
Discussed reforms to the Bureau of Land Management's Wild Horse and Burro program (Steve Only).
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
Lobbied in support of the following full bills: H.R. 909, the Pet and Women Safety Act; H.R. 1456, the Shark Fin Sales Elimination Act; H.R. 1494, the Preventing Cruelty and Torture Act; H.R. 1847, the Prevent All Soring Tactics Act; H.R. 2790, the Humane Cosmetics Act; H.R. 2651, the Horseracing Integrity Act; H.R.1406, the Dog and Cat Meat Trade Prohibition Act; and H.R.4202, Parity in Animal Cruelty Enforcement Act.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
Modernization of Cosmetic Regulations
H.R. 575 - Cosmetic Modernization Amendments of 2017
S. 2003 - FDA Cosmetic Safety and Modernization Act
S. 1113 - Personal Care Products Safety Act
Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients
H.R. 2790 - Humane Cosmetics Act
FDA Regulation of OTC Drugs
OTC Drug Monograph Reform
Ingredient Disclosure - Cleaning Products
Client expense: Not reported · Firm income: $5,000
Cited source text, amounts, lobbyists, and targets
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions.
- S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions.
- H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions.
- H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions.
- S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions.
- Issues regarding drug pricing.
- Issues related to diagnostic reform.
- Issues related to blood glucose meters.
- S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions
- S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions
- S 204/HR 878, Right to Try Act of 2017, regarding all provisions
- HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions
- HR 1703, Medical Product Communications Act of 2017, regarding all provisions
- Issues related to VA procurement of medical devices
- HR 2474, Medical Product Review Harmonization Act, regarding all provisions
- HR 2144, Risk Based Classification of Accessories Act
- Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects
- S.113, "Personal Care Products Safety Act", regarding all provisions
- HR 2790, "Humane Cosmetics Act", regarding all provisions
- Issues related to over the counter medicine regulatory reform
- HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions
- Issues regarding medical device repeal
- Issues regarding NIH Funding
- HR 2164, "Medical Device Safety Act", regarding all provisions
- Issues related to 340B
Client expense: $810,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Lobbied in support of the following full bills: H.R. 909, the Pet and Women Safety Act; H.R. 1456, the Shark Fin Sales Elimination Act; H.R. 1494, the Preventing Cruelty and Torture Act; H.R. 1818, the Big Cat Public Safety Act; H.R. 1847, the Prevent All Soring Tactics Act; H.R. 2790, the Humane Cosmetics Act; H.R. 2651, the Horseracing Integrity Act; and H.R. 1406, the Dog and Cat Meat Trade Prohibition Act.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
Legislation:
H.R. 1818 Big Cat Public Safety Act
H.R. 2790 Humane Cosmetics Act
H.R. 1753/S. 741 Opportunities for Fairness in Farming Act
H.R. 1752/S. 740 Voluntary Checkoff Program Participation Act
H.R. 2651 Thoroughbred Horseracing Integrity Act
H.R. 1494/S. 654 Preventing Animal Cruelty and Torture Act
H.R. 1847 Prevent All Soring Tactics Act
H.R. 1338 Horse Protection Amendments Act
H.R. 909/S. 322 Pet and Women Safety Act
H.R. 113 Safeguarding American Food Exports Act
H.R. 1456/S. 793 Shark Fin Trade Elimination Act
H.R. 1406 Dog and Cat Meat Trade Prohibition Act of 2017
H.R. 1368/S. 503 Animal Welfare Accountability and Transparency Act
Farm Bill (not yet introduced)
Puppy Mill Bills (not yet introduced)
H.R. 2887 No Regulation without Representation Act of 2017
Animal Welfare in Agricultural Research Endeavors Act (not yet introduced)
H.R. 424/S. 164 Gray Wolf State Management Act
S. 733 Sportsmens Act
S. 1514 Hunting Heritage and Environmental Legacy Preservation (HELP) for Wildlife Act
H.R. 226 African Elephant Conservation and Legal Ivory Possession Act
H.R. 1243 Battlefield Excellence through Superior Training Practices Act
H.R. 2810 and S. 1519 National Defense Authorization Act for Fiscal Year 2018
H.R. 1438 Refuge from Cruel Trapping Act
H.R. 1584 Orca Responsibility and Care Advancement Act
H. Res. 244 Expressing support for Japan to end its whaling in all forms and to strengthen measures to conserve whale populations
H.R. 1817 Chemical Poisons Reduction Act
H.R. 2542 Federal Bird-Safe Buildings Act of 2017
H.R. 2083 Endangered Salmon and Fisheries Predation Prevention Act
H.R. 1759 Traveling Exotic Animal and Public Safety Protection Act
S. 951 Regulatory Accountability Act
H.R. 816 FACT Act
H.R. 3197 Preventing Unkind and Painful Procedures and Experiments on Respected Species (PUPPERS) Act
Rulemaking and Federal Government Decisions and Policies:
Potential revisions to the Endangered Species Act
Upgrading dog dealer standards
Organic Livestock and Poultry Protection Rule
Horse Protection Act Rule
Animal Welfare Act and Horse Protection Act online records
Nominations
Sonny Perdue, Department of Agriculture
Cited source text, amounts, lobbyists, and targets
Lobbied in support of the following full bills: H.R. 909, the Pet and Women Safety Act; H.R. 1456, the Shark Fin Sales Elimination Act; H.R. 1494, the Preventing Cruelty and Torture Act; H.R. 1818, the Big Cat Public Safety Act; and H.R. 1847, the Prevent All Soring Tactics Act. (Steve) Lobbied in support of H.R. 2790, the Humane Cosmetics Act and H.R. 2651, the Horseracing Integrity Act. (Matt) (House)
Lobbied in support of a Congressional sign-on letter urging adequate funding in the Fiscal Year 2018 Agriculture Appropriations bill to allow USDA to enforce the Animal Welfare Act, the Horse Protection Act, and the Humane Methods of Slaughter Act. (Senate)
Client expense: Not reported · Firm income: $20,000